163 related articles for article (PubMed ID: 7586252)
1. N-acetylcysteine in combination with nitroglycerin and streptokinase for the treatment of evolving acute myocardial infarction. Safety and biochemical effects.
Arstall MA; Yang J; Stafford I; Betts WH; Horowitz JD
Circulation; 1995 Nov; 92(10):2855-62. PubMed ID: 7586252
[TBL] [Abstract][Full Text] [Related]
2. Effect of N-acetylcysteine on oxidative stress and ventricular function in patients with myocardial infarction.
Yesilbursa D; Serdar A; Senturk T; Serdar Z; Sağ S; Cordan J
Heart Vessels; 2006 Jan; 21(1):33-7. PubMed ID: 16440146
[TBL] [Abstract][Full Text] [Related]
3. N-acetylcysteine in combination with nitroglycerin and streptokinase for the treatment of evolving acute myocardial infarction: safety and biochemical effects.
Simon K; Szépvölgyi A
Circulation; 1996 Oct; 94(7):1791. PubMed ID: 8840884
[No Abstract] [Full Text] [Related]
4. Combined use of nitroglycerin and N-acetylcysteine in the management of unstable angina pectoris.
Horowitz JD; Henry CA; Syrjanen ML; Louis WJ; Fish RD; Smith TW; Antman EM
Circulation; 1988 Apr; 77(4):787-94. PubMed ID: 3127076
[TBL] [Abstract][Full Text] [Related]
5. Prompt improvement of left ventricular function and preservation of topography with combined reperfusion and intravenous nitroglycerin in acute myocardial infarction.
Jugdutt BI; Schwarz-Michorowski BL; Tymchak WJ; Burton JR
Cardiology; 1997; 88(2):170-9. PubMed ID: 9096919
[TBL] [Abstract][Full Text] [Related]
6. Streptokinase-induced transient aggravation of myocardial injury.
Arstall MA; Stewart S; Haste MA; Horowitz JD
Int J Cardiol; 1995 Jun; 50(2):107-16. PubMed ID: 7591321
[TBL] [Abstract][Full Text] [Related]
7. Fibrinolytic therapy and n-acetylocysteine in the treatment of patients with acute myocardial infarction: its influence on authentic plasma hydroperoxide levels and polymorphonuclear neutrophil oxygen metabolism.
Sajkowska A; Wykretowicz A; Szczepanik A; Kempa M; Minczykowski A; Wysocki H
Cardiology; 1999; 91(1):60-5. PubMed ID: 10393400
[TBL] [Abstract][Full Text] [Related]
8. Early Use of N-acetylcysteine With Nitrate Therapy in Patients Undergoing Primary Percutaneous Coronary Intervention for ST-Segment-Elevation Myocardial Infarction Reduces Myocardial Infarct Size (the NACIAM Trial [N-acetylcysteine in Acute Myocardial Infarction]).
Pasupathy S; Tavella R; Grover S; Raman B; Procter NEK; Du YT; Mahadavan G; Stafford I; Heresztyn T; Holmes A; Zeitz C; Arstall M; Selvanayagam J; Horowitz JD; Beltrame JF
Circulation; 2017 Sep; 136(10):894-903. PubMed ID: 28634219
[TBL] [Abstract][Full Text] [Related]
9. Thiol-containing agents in the management of unstable angina pectoris and acute myocardial infarction.
Horowitz JD
Am J Med; 1991 Sep; 91(3C):113S-117S. PubMed ID: 1928201
[TBL] [Abstract][Full Text] [Related]
10. N-acetylcysteine attenuates nitroglycerin tolerance in patients with angina pectoris and normal left ventricular function.
Pizzulli L; Hagendorff A; Zirbes M; Jung W; Lüderitz B
Am J Cardiol; 1997 Jan; 79(1):28-33. PubMed ID: 9024731
[TBL] [Abstract][Full Text] [Related]
11. Infarct Size Limitation: acute N-acetylcysteine defense (ISLAND trial): preliminary analysis and report after the first 30 patients.
Sochman J; Vrbská J; Musilová B; Rocek M
Clin Cardiol; 1996 Feb; 19(2):94-100. PubMed ID: 8821417
[TBL] [Abstract][Full Text] [Related]
12. Impact of high-dose N-acetylcysteine versus placebo on contrast-induced nephropathy and myocardial reperfusion injury in unselected patients with ST-segment elevation myocardial infarction undergoing primary percutaneous coronary intervention. The LIPSIA-N-ACC (Prospective, Single-Blind, Placebo-Controlled, Randomized Leipzig Immediate PercutaneouS Coronary Intervention Acute Myocardial Infarction N-ACC) Trial.
Thiele H; Hildebrand L; Schirdewahn C; Eitel I; Adams V; Fuernau G; Erbs S; Linke A; Diederich KW; Nowak M; Desch S; Gutberlet M; Schuler G
J Am Coll Cardiol; 2010 May; 55(20):2201-9. PubMed ID: 20466200
[TBL] [Abstract][Full Text] [Related]
13. Hemodynamic effects of nitroglycerin in acute myocardial infarction.
Williams DO; Amsterdam EA; Mason DT
Circulation; 1975 Mar; 51(3):421-7. PubMed ID: 806394
[TBL] [Abstract][Full Text] [Related]
14. Serial angiographic assessment of coronary artery obstruction and collateral flow in acute myocardial infarction. Report from the second Mount Sinai-New York University Reperfusion Trial.
Rentrop KP; Feit F; Sherman W; Thornton JC
Circulation; 1989 Nov; 80(5):1166-75. PubMed ID: 2509103
[TBL] [Abstract][Full Text] [Related]
15. Reduction of ischemia-reperfusion syndrome after abdominal aortic aneurysmectomy by N-acetylcysteine but not mannitol.
Kretzschmar M; Klein U; Palutke M; Schirrmeister W
Acta Anaesthesiol Scand; 1996 Jul; 40(6):657-64. PubMed ID: 8836257
[TBL] [Abstract][Full Text] [Related]
16. Accelerated infusion of streptokinase in acute myocardial infarction results in better TIMI flow grade in infarct-related artery.
Dwivedi SK; Saran RK; Narain VS; Bansal S; Gupta R; Puri VK
Indian Heart J; 2000; 52(1):40-4. PubMed ID: 10820932
[TBL] [Abstract][Full Text] [Related]
17. Improved reperfusion and clinical outcome with enoxaparin as an adjunct to streptokinase thrombolysis in acute myocardial infarction. The AMI-SK study.
Simoons M; Krzemiñska-Pakula M; Alonso A; Goodman S; Kali A; Loos U; Gosset F; Louer V; Bigonzi F;
Eur Heart J; 2002 Aug; 23(16):1282-90. PubMed ID: 12175665
[TBL] [Abstract][Full Text] [Related]
18. Double bolus of 0.75 MU streptokinase plus enoxaparin versus front-loaded alteplase plus unfractionated heparin in ST-segment elevation myocardial infarction.
Tatu-Chiţoiu G; Teodorescu C; Dan M; Căpraru P; Guran M; Istrătescu O; Tatu-Chiţoiu A; Bumbu A; Dorobanţu M
Rom J Intern Med; 2003; 41(4):395-408. PubMed ID: 15526522
[TBL] [Abstract][Full Text] [Related]
19. Nitroglycerine/N-acetylcysteine in the management of unstable angina pectoris.
Horowitz JD; Henry CA; Syrjanen ML; Louis WJ; Fish RD; Antman EM; Smith TW
Eur Heart J; 1988 Jan; 9 Suppl A():95-100. PubMed ID: 3137075
[TBL] [Abstract][Full Text] [Related]
20. Potentiation of the cardiovascular effects of nitroglycerin by N-acetylcysteine.
Horowitz JD; Antman EM; Lorell BH; Barry WH; Smith TW
Circulation; 1983 Dec; 68(6):1247-53. PubMed ID: 6139183
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
